Matthias Friedrich

Matthias Friedrich

Company: Amgen

Job title: Scientific Director

Seminars:

AMG 701 – A BCMA-Targeting BiTE® Molecule for the Treatment of Multiple Myeloma – From Bench to Bedside 10:30 am

Analyzing nonclinical in vitro and in vivo characterization Determination of a Safe FiH Start Dose Evaluating results of a Dose Escalation FiH Phase 1 StudyRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.